Literature DB >> 23651736

Th1-, Th2-, and Th17-related cytokine and chemokine receptor mRNA and protein expression in the brain tissues, T cells, and macrophages of dogs with necrotizing and granulomatous meningoencephalitis.

E-S Park1, K Uchida, H Nakayama.   

Abstract

Necrotizing meningoencephalitis (NME), necrotizing leukoencephalitis (NLE), and granulomatous meningoencephalomyelitis (GME) are idiopathic inflammatory diseases in the central nervous system (CNS) of dogs. In our previous study, the proportion of inflammatory cells, except for CD3-positive T cells, were not different in parenchymal and perivascular lesions in the brain. However, breed specificities, clinical courses, and specific lesions were distinct among these diseases. Thus, similarities and differences in the pathologies of these diseases have been implied. In this study, the messenger RNA (mRNA) and/or protein expression levels of cytokines and chemokine receptors were investigated in NME (n = 2), NLE (n = 4), and GME (n = 2) cases, and their relationship in the formation of specific lesions was discussed. The mRNA and protein expression levels of interferon (IFN)-γ and interleukin (IL)-17 were marked in NME and GME, respectively. The mRNA expression levels of CXCR3 and CCR2 were also marked in NME and GME, respectively. The results of double-labeling immunofluorescence, used to identify cells producing IL-17 in these lesions, showed that most CD163-positive macrophages/microglia but fewer CD3-positive T cells were IL-17 positive in GME. These results indicate that IFN-γ plays a key role in NME lesions and that the macrophages/microglia that infiltrate brain lesions producing IL-17 are more important in GME than T cells.

Entities:  

Keywords:  GME; NLE; NME; canine; cytokine

Mesh:

Substances:

Year:  2013        PMID: 23651736     DOI: 10.1177/0300985813488957

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  12 in total

1.  Serum levels of innate immunity cytokines are elevated in dogs with metaphyseal osteopathy (hypertrophic osteodytrophy) during active disease and remission.

Authors:  Noa Safra; Peta L Hitchens; Emanual Maverakis; Anupam Mitra; Courtney Korff; Eric Johnson; Amir Kol; Michael J Bannasch; Niels C Pedersen; Danika L Bannasch
Journal:  Vet Immunol Immunopathol       Date:  2016-08-03       Impact factor: 2.046

2.  Neuroinflammatory diseases of the central nervous system of dogs: A retrospective study of 207 cases (2008-2019).

Authors:  Jessica A Elbert; Wilson Yau; Daniel R Rissi
Journal:  Can Vet J       Date:  2022-02       Impact factor: 1.008

3.  Contribution of Schwann Cells to Remyelination in a Naturally Occurring Canine Model of CNS Neuroinflammation.

Authors:  Kristel Kegler; Ingo Spitzbarth; Ilka Imbschweiler; Konstantin Wewetzer; Wolfgang Baumgärtner; Frauke Seehusen
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

4.  Th17 Pathway As a Target for Multipotent Stromal Cell Therapy in Dogs: Implications for Translational Research.

Authors:  A Kol; N J Walker; M Nordstrom; D L Borjesson
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

5.  Th17-skewed immune response and cluster of differentiation 40 ligand expression in canine steroid-responsive meningitis-arteritis, a large animal model for neutrophilic meningitis.

Authors:  Jessica Freundt-Revilla; Arianna Maiolini; Regina Carlson; Martin Beyerbach; Kai Rentmeister; Thomas Flegel; Andrea Fischer; Andrea Tipold
Journal:  J Neuroinflammation       Date:  2017-01-23       Impact factor: 8.322

6.  Leukocyte and cytokine variables in asymptomatic Pugs at genetic risk of necrotizing meningoencephalitis.

Authors:  Rebecca Windsor; Samuel D Stewart; Joshua Talboom; Candace Lewis; Marcus Naymik; Ignazio S Piras; Stefan Keller; Dori L Borjesson; Gary Clark; Chand Khanna; Matthew Huentelman
Journal:  J Vet Intern Med       Date:  2021-10-23       Impact factor: 3.333

7.  Meningeal B Cell Clusters Correlate with Submeningeal Pathology in a Natural Model of Multiple Sclerosis.

Authors:  Molly E Church; Guadalupe Ceja; Megan McGeehan; Miles C Miller; Priscilla Farias; Melissa D Sánchez; Gary P Swain; Charles-Antoine Assenmacher; Edward G Stopa; Charles H Vite; Amit Bar-Or; Jorge I Alvarez
Journal:  J Immunol       Date:  2021-06-23       Impact factor: 5.426

8.  Placenta-derived multipotent mesenchymal stromal cells: a promising potential cell-based therapy for canine inflammatory brain disease.

Authors:  Rogério Martins Amorim; Kaitlin C Clark; Naomi J Walker; Priyadarsini Kumar; Kyle Herout; Dori L Borjesson; Aijun Wang
Journal:  Stem Cell Res Ther       Date:  2020-07-22       Impact factor: 6.832

9.  Human Chronic Necrotizing Granulomatous Meningoencephalitis: A Novel Case Report.

Authors:  Alexus P Taddonio; Eric J Veloso; Kelly J Baldwin
Journal:  Case Rep Neurol       Date:  2018-10-24

10.  The Expression of Selected Factors Related to T Lymphocyte Activity in Canine Mammary Tumors.

Authors:  Joanna K Bujak; Iwona M Szopa; Rafał Pingwara; Olga Kruczyk; Natalia Krzemińska; Joanna Mucha; Kinga Majchrzak-Kuligowska
Journal:  Int J Mol Sci       Date:  2020-03-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.